S0325 Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

This study is ongoing, but not recruiting participants.

Study NCT00070499 Information provided by Southwest Oncology Group

First Received: October 3, 2003 Last Updated: July 19, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Primary Completion Date:	March 2009 (Final data collection date for primary outcome measure)